Enjoy complimentary customisation on priority with our Enterprise License!
The human platelet lysate market size is forecast to increase by 11.06 thousand at a CAGR of 3.64% between 2023 and 2028. The market is experiencing significant growth due to several key drivers. The rising prevalence of chronic diseases, such as cancer and diabetes, is fueling the demand for human platelet lysate in biomedical research and therapeutic applications. Additionally, growing investments in stem cell research have created the need for human platelet lysate as a critical component in the expansion and differentiation of stem cells. Strict regulations and quality control requirements for human-derived products ensure the market's sustainability and growth. These factors, combined with the increasing awareness of the potential applications of human platelet lysate, make it an attractive market for investors and industry players alike.
The Market is a significant segment within the Biomedical industry, primarily used in Regenerative Medicine and Cell Culture Techniques. This market is driven by the increasing demand for innovative treatments in various Clinical Applications, including Chronic Diseases such as Parkinson's Disease and Neurodegenerative Disorders, Stem Cell Research, Tissue Engineering, and Cell Therapy. Fetal Bovine Serum, a traditional medium for cell culture, is being replaced by Human Platelet Lysate due to safety and efficiency concerns. Ethical considerations have also played a role in the shift towards using human-derived materials. Cytokines present in Human Platelet Lysate play a crucial role in cellular proliferation and differentiation potential. Platelet-derived growth factors are essential for therapeutic applications in areas like Wound Healing, Cancer Therapy, and Pharmaceutical and Healthcare facilities. The Regulatory Landscape for Human Platelet Lysate is evolving, with a focus on standardized, safe, and reproducible results. Heparin-Free HPL and Biogelx are emerging trends in this market. The market is expected to grow substantially due to the increasing demand for therapeutic applications in various clinical trials for Infectious diseases and other therapeutic areas.
The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in USD Thousand for the period 2024-2028, as well as historical data from 2018 - 2022 for the following segments.
The heparin free human platelet lysate segment is estimated to witness significant growth during the forecast period. Human Platelet Lysate (HPL), a crucial component in Biomedical research, plays a significant role in the advancement of Regenerative Medicine through Cell Culture Techniques. Fetal Bovine Serum (FBS) traditionally used in cell culture has safety and efficiency concerns, leading to the exploration of alternative sources.
Get a glance at the market share of various regions Download the PDF Sample
The heparin free human platelet lysate segment was the largest segment and was valued at USD 31,441.60 in 2018. HPL, derived from platelets, offers standardized, safe, and reproducible results with cell performance superior to FBS. Ethical considerations surrounding FBS usage have fueled the demand for HPL in Stem Cell Research and Tissue Engineering applications. Cytokines present in HPL contribute to the therapeutic potential in treating Neurodegenerative Disorders like Parkinson's Disease and Chronic Diseases. Hence, such factors are fuelling the growth of this segment during the forecast period.
For more insights on the market share of various regions Download PDF Sample now!
North America is estimated to contribute 43% to the growth of the global market during the forecast period. Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period. The Market is a significant segment within the Pharmaceutical and Healthcare facilities sectors. This market is driven by the increasing demand for advanced Cell culture systems in Biomedical research, Drug discovery, cellular proliferation and Cell-based therapeutics. Companies like Biogelx are leading innovators in this field, offering high-quality solutions derived from platelets for various disease indications, including tissue repair and clotting. These bioactive compounds play a crucial role in cell proliferation and maintaining cellular integrity. Hence, such factors are driving the market in North America during the forecast period.
Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
Rising prevalence of chronic diseases is notably driving market growth. The market is experiencing significant growth due to the increasing prevalence of chronic diseases, particularly noncommunicable diseases (NCDs). NCDs are long-term conditions caused by a combination of genetic, physiological, environmental, and behavioral factors.
Moreover, the primary types of NCDs include cardiovascular diseases, cancers, chronic respiratory diseases, and diabetes. According to the World Health Organization (WHO), cardiovascular diseases are the leading cause of NCD-related deaths, accounting for approximately 17.9 million fatalities annually. Thus, such factors are driving the growth of the market during the forecast period.
Growing investments in stem cell research is the key trend in the market. The market is experiencing significant growth due to its increasing utilization in biomedical applications, particularly in the field of regenerative medicine. This market is driven by the expanding investment in research and development, specifically in stem cell research, which holds immense potential for treating various chronic diseases, including neurodegenerative disorders like Parkinson's disease.
Moreover, human platelet lysate, a rich source of cytokines and platelet-derived growth factors, is a preferred supplement for cell culture techniques due to its compatibility with human cells and its ability to promote safe, standardized, and reproducible results. Thus, such trends will shape the growth of the market during the forecast period.
Stringent regulations and quality control requirements for human-derived products is the major challenge that affects the growth of the market. The market in the realm of biomedical applications, particularly in Regenerative Medicine, is witnessing significant regulatory hurdles. These challenges are multifaceted, influencing both the production and commercialization of products.
Moreover, the stringent regulatory landscape is intended to guarantee safety, efficiency, and quality, serving as a formidable barrier for manufacturers. In the US, the Food and Drug Administration (FDA) mandates rigorous requirements for the collection, processing, and testing of human-derived products to prevent contamination and maintain stringent safety standards. Hence, the above factors will impede the growth of the market during the forecast period.
The market forecasting report includes the adoption lifecycle of the market, covering from the innovator's stage to the laggard's stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.
Customer Landscape
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.
BioLife Solutions Inc: The company offers human platelet lysate supplements such as Stimulate, Pathogen-Reduced Human Platelet Lysate nLiven PR and T-Liven PR.
The market research and growth report also includes detailed analyses of the competitive landscape of the market and information about key companies, including:
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
The market is a significant segment in the Biomedical industry, particularly in the field of Regenerative Medicine. HPL plays a crucial role in Cell Culture Techniques, providing essential growth factors for various applications. Fetal Bovine Serum (FBS) has traditionally been used, but HPL offers advantages such as safety and efficiency. Ethical considerations have led to a shift towards using HPL in research and therapy. HPL contains cytokines, which are essential for the growth and differentiation of cells, making it an ideal choice for Stem Cell Research and Tissue Engineering. HPL is used in the therapeutic development of treatments for Neurodegenerative Disorders like Parkinson's Disease and other Chronic Diseases. The Regulatory Landscape for HPL is evolving, with a focus on standardized, safe, and cell performance for reproducible results. Heparin-Free HPL is gaining popularity due to its advantages over heparin-based HPL. HPL is used in Stem Cell Therapy, Clinical Trials, and innovative treatments for various clinical applications. Fibroblast proliferation and Extracellular Matrix Production are other areas where HPL is used in cell culture. Patent License Agreements are crucial in the HPL market, ensuring the intellectual property rights of companies producing and using HPL. Mesenchymal Stem Cells are a significant application area for HPL, with Platelet-derived growth factors playing a key role in cellular proliferation and differential potential. Infectious diseases are also being targeted with HPL, offering potential therapeutic benefits.
Market Scope |
|
Report Coverage |
Details |
Page number |
201 |
Base year |
2023 |
Historic period |
2018 - 2022 |
Forecast period |
2024-2028 |
Growth momentum & CAGR |
Accelerate at a CAGR of 3.64% |
Market growth 2024-2028 |
USD 11,06 Th |
Market structure |
Fragmented |
YoY growth 2023-2024(%) |
3.48 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 43% |
Key countries |
US, UK, and China |
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
Key companies profiled |
Amerigo Scientific, AventaCell BioMedical Corp. Ltd., BioLife Solutions Inc., Compass Biomedical Inc., Creative Biolabs, GeminiBio, Macopharma SA, Merck KGaA, Mill Creek Life Sciences Inc., MP Biomedicals Inc., PAN-Biotech GmbH, PL BioScience GmbH, Regenexx Des Moines, Sartorius AG, Sartorius CellGenix GmbH, Serana Europe GmbH, STEMCELL Technologies Inc., TCS Biosciences Ltd., TRINOVA BIOCHEM GmbH, and ZenBio Inc. |
Market dynamics |
Parent market analysis, market report , market forecast , Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this market research report to meet your requirements. Get in touch
1 Executive Summary
2 Technavio Analysis
3 Market Landscape
4 Market Sizing
5 Historic Market Size
6 Qualitative Analysis
7 Five Forces Analysis
8 Market Segmentation by Type
9 Market Segmentation by Application
10 Customer Landscape
11 Geographic Landscape
12 Drivers, Challenges, and Opportunity/Restraints
13 Competitive Landscape
14 Competitive Analysis
15 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.